These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 34310218)

  • 1. Population Pharmacokinetics of Diethylcarbamazine in Patients with Lymphatic Filariasis and Healthy Individuals.
    Bala V; Chhonker YS; Alshehri A; Edi C; Bjerum CM; Koudou BG; King CL; Murry DJ
    Antimicrob Agents Chemother; 2021 Sep; 65(10):e0031721. PubMed ID: 34310218
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics, safety, and efficacy of a single co-administered dose of diethylcarbamazine, albendazole and ivermectin in adults with and without Wuchereria bancrofti infection in Côte d'Ivoire.
    Edi C; Bjerum CM; Ouattara AF; Chhonker YS; Penali LK; Méité A; Koudou BG; Weil GJ; King CL; Murry DJ
    PLoS Negl Trop Dis; 2019 May; 13(5):e0007325. PubMed ID: 31107869
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Population pharmacokinetic model of ivermectin in mass drug administration against lymphatic filariasis.
    Alshehri A; Chhonker YS; Bala V; Edi C; Bjerum CM; Koudou BG; John LN; Mitjà O; Marks M; King CL; Murry DJ
    PLoS Negl Trop Dis; 2023 Jun; 17(6):e0011319. PubMed ID: 37262040
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heterogeneous response of Wuchereria bancrofti-infected persons to diethylcarbamazine (DEC) and its implications for the Global Programme to Eliminate Lymphatic Filariasis (GPELF).
    Sankari T; Subramanian S; Hoti SL; Pani SP; Jambulingam P; Das PK
    Parasitol Res; 2021 Jan; 120(1):311-319. PubMed ID: 33146778
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and tolerability of treatment with single doses of diethylcarbamazine (DEC) and DEC plus albendazole (ABZ) for three consecutive years in lymphatic filariasis: a field study in India.
    Kshirsagar NA; Gogtay NJ; Garg BS; Deshmukh PR; Rajgor DD; Kadam VS; Thakur PA; Gupta A; Ingole NS; Lazdins-Helds JK
    Parasitol Res; 2017 Oct; 116(10):2683-2694. PubMed ID: 28785847
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy, Safety, and Pharmacokinetics of Coadministered Diethylcarbamazine, Albendazole, and Ivermectin for Treatment of Bancroftian Filariasis.
    Thomsen EK; Sanuku N; Baea M; Satofan S; Maki E; Lombore B; Schmidt MS; Siba PM; Weil GJ; Kazura JW; Fleckenstein LL; King CL
    Clin Infect Dis; 2016 Feb; 62(3):334-341. PubMed ID: 26486704
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of Brugia timori and Wuchereria bancrofti infections in Indonesia using DEC or a combination of DEC and albendazole: adverse reactions and short-term effects on microfilariae.
    Supali T; Ismid IS; Rückert P; Fischer P
    Trop Med Int Health; 2002 Oct; 7(10):894-901. PubMed ID: 12358626
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of six rounds of single-dose mass administration of diethylcarbamazine or ivermectin on the transmission of Wuchereria bancrofti by Culex quinquefasciatus and its implications for lymphatic filariasis elimination programmes.
    Ramaiah KD; Das PK; Vanamail P; Pani SP
    Trop Med Int Health; 2003 Dec; 8(12):1082-92. PubMed ID: 14641843
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Imported bancroftian filariasis: diethylcarbamazine response and benzimidazole susceptibility of Wuchereria bancrofti in dynamic cross-border migrant population targeted by the National Program to Eliminate Lymphatic Filariasis in South Thailand.
    Bhumiratana A; Pechgit P; Koyadun S; Siriaut C; Yongyuth P
    Acta Trop; 2010 Feb; 113(2):121-8. PubMed ID: 19835831
    [TBL] [Abstract][Full Text] [Related]  

  • 10. How Thailand eliminated lymphatic filariasis as a public health problem.
    Rojanapanus S; Toothong T; Boondej P; Thammapalo S; Khuanyoung N; Santabutr W; Prempree P; Gopinath D; Ramaiah KD
    Infect Dis Poverty; 2019 May; 8(1):38. PubMed ID: 31130143
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of effectiveness of diethylcarbamazine/albendazole combination in reduction of Wuchereria bancrofti infection using multiple infection parameters.
    Wamae CN; Njenga SM; Ngugi BM; Mbui J; Njaanake HK
    Acta Trop; 2011 Sep; 120 Suppl 1():S33-8. PubMed ID: 20933491
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lymphatic pathology in asymptomatic and symptomatic children with Wuchereria bancrofti infection in children from Odisha, India and its reversal with DEC and albendazole treatment.
    Kar SK; Dwibedi B; Das BK; Agrawala BK; Ramachandran CP; Horton J
    PLoS Negl Trop Dis; 2017 Oct; 11(10):e0005631. PubMed ID: 29059186
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An open label, randomized clinical trial to compare the tolerability and efficacy of ivermectin plus diethylcarbamazine and albendazole vs. diethylcarbamazine plus albendazole for treatment of brugian filariasis in Indonesia.
    Supali T; Djuardi Y; Christian M; Iskandar E; Alfian R; Maylasari R; Destani Y; Lomiga A; Minggu D; Lew D; Bogus J; Weil GJ; Fischer PU
    PLoS Negl Trop Dis; 2021 Mar; 15(3):e0009294. PubMed ID: 33780481
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of six rounds of single dose mass treatment with diethylcarbamazine or ivermectin on Wuchereria bancrofti infection and its implications for lymphatic filariasis elimination.
    Ramaiah KD; Vanamail P; Pani SP; Yuvaraj J; Das PK
    Trop Med Int Health; 2002 Sep; 7(9):767-74. PubMed ID: 12225508
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Border and imported bancroftian filariases: baseline seroprevalence in sentinel populations exposed to infections with Wuchereria bancrofti and concomitant HIV at the start of diethylcarbamazine mass treatment in Thailand.
    Bhumiratana A; Koyadun S; Srisuphanunt M; Satitvipawee P; Limpairojn N; Gaewchaiyo G
    Southeast Asian J Trop Med Public Health; 2005 Mar; 36(2):390-407. PubMed ID: 15916046
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of mass drug administration in the program to control imported lymphatic filariasis in Thailand.
    Toothong T; Tipayamongkholgul M; Suwannapong N; Suvannadabba S
    BMC Public Health; 2015 Sep; 15():975. PubMed ID: 26415693
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Persistence of lymphatic filarial infection in the paediatric population of rural community, after six rounds of annual mass drug administrations.
    Sunish IP; Munirathinam A; Kalimuthu M; Ashok Kumar V; Tyagi BK
    J Trop Pediatr; 2014 Jun; 60(3):245-8. PubMed ID: 24343822
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An analysis of the safety of the single dose, two drug regimens used in programmes to eliminate lymphatic filariasis.
    Horton J; Witt C; Ottesen EA; Lazdins JK; Addiss DG; Awadzi K; Beach MJ; Belizario VY; Dunyo SK; Espinel M; Gyapong JO; Hossain M; Ismail MM; Jayakody RL; Lammie PJ; Makunde W; Richard-Lenoble D; Selve B; Shenoy RK; Simonsen PE; Wamae CN; Weerasooriya MV
    Parasitology; 2000; 121 Suppl():S147-60. PubMed ID: 11386686
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The influence of the mass administration of diethylcarbamazine, alone or with albendazole, on the prevalence of filarial antigenaemia.
    Rajendran R; Sunish IP; Mani TR; Munirathinam A; Abdullah SM; Augustin DJ; Satyanarayana K
    Ann Trop Med Parasitol; 2002 Sep; 96(6):595-602. PubMed ID: 12396322
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tolerability and efficacy of a three-age class dosage schedule of Diethylcarbamazine citrate (DEC) in the treatment of microfilaria carriers of Wuchereria bancrofti and its implications in mass drug administration (MDA) strategy for elimination of lymphatic filariasis (LF).
    Pani SP; Das LK; Vanamail P
    J Commun Dis; 2005 Mar; 37(1):12-7. PubMed ID: 16637395
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.